Steven L. Hoerter - Net Worth and Insider Trading
Steven L. Hoerter Net Worth
The estimated net worth of Steven L. Hoerter is at least $3 Million dollars as of 2024-11-10. Steven L. Hoerter is the President and CEO of Deciphera Pharmaceuticals Inc and owns about 72,763 shares of Deciphera Pharmaceuticals Inc (DCPH) stock worth over $2 Million. Steven L. Hoerter is the Chief Commercial Officer of Agios Pharmaceuticals Inc and owns about 10,941 shares of Agios Pharmaceuticals Inc (AGIO) stock worth over $646,175. Steven L. Hoerter is also the See Remarks of Clovis Oncology Inc and owns about 0 shares of Clovis Oncology Inc (CLVSQ) stock worth over $0. Details can be seen in Steven L. Hoerter's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven L. Hoerter has not made any transactions after 2023-12-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Steven L. Hoerter
Steven L. Hoerter Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven L. Hoerter owns 6 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) , Constellation Pharmaceuticals Inc (CNST) , and Agios Pharmaceuticals Inc (AGIO) among others .
Click here to see the complete history of Steven L. Hoerter’s form 4 insider trades.
Insider Ownership Summary of Steven L. Hoerter
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2023-12-13 | director |
| CNST | Constellation Pharmaceuticals Inc | 2020-06-04 | director |
| AGIO | Agios Pharmaceuticals Inc | 2019-03-04 | Chief Commercial Officer |
 | | 2018-02-08 | director |
| | 2015-03-05 | SEE REMARKS |
| | 2021-08-13 | director |
Steven L. Hoerter Latest Holdings Summary
Steven L. Hoerter currently owns a total of 3 stocks. Among these stocks, Steven L. Hoerter owns 72,763 shares of Deciphera Pharmaceuticals Inc (DCPH) as of December 13, 2023, with a value of $2 Million and a weighting of 74.24%. Steven L. Hoerter owns 10,941 shares of Agios Pharmaceuticals Inc (AGIO) as of March 4, 2019, with a value of $646,175 and a weighting of 25.76%. Steven L. Hoerter also owns 0 shares of Clovis Oncology Inc (CLVSQ) as of March 5, 2015, with a value of $0 and a weighting of 0%.
Latest Holdings of Steven L. Hoerter
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2023-12-13 | 72,763 | 25.59 | 1,862,005 |
| AGIO | Agios Pharmaceuticals Inc | 2019-03-04 | 10,941 | 59.06 | 646,175 |
| CLVSQ | Clovis Oncology Inc | 2015-03-05 | 0 | 0.02 | 0 |
Holding Weightings of Steven L. Hoerter
Steven L. Hoerter Form 4 Trading Tracker
According to the SEC Form 4 filings, Steven L. Hoerter has made a total of 4 transactions in Deciphera Pharmaceuticals Inc (DCPH) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Deciphera Pharmaceuticals Inc is the sale of 30,664 shares on December 13, 2023, which brought Steven L. Hoerter around $471,306.
According to the SEC Form 4 filings, Steven L. Hoerter has made a total of 0 transactions in Agios Pharmaceuticals Inc (AGIO) over the past 5 years. The most-recent trade in Agios Pharmaceuticals Inc is the sale of 10,000 shares on March 4, 2019, which brought Steven L. Hoerter around $670,100.
According to the SEC Form 4 filings, Steven L. Hoerter has made a total of 0 transactions in Clovis Oncology Inc (CLVSQ) over the past 5 years. The most-recent trade in Clovis Oncology Inc is the sale of 20,000 shares on March 5, 2015, which brought Steven L. Hoerter around $2 Million.
Insider Trading History of Steven L. Hoerter
- 1
Steven L. Hoerter Trading Performance
Steven L. Hoerter Ownership Network
Ownership Network List of Steven L. Hoerter
Ownership Network Relation of Steven L. Hoerter
Steven L. Hoerter Owned Company Details
What does Deciphera Pharmaceuticals Inc do?
Who are the key executives at Deciphera Pharmaceuticals Inc?
Steven L. Hoerter is the director of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include SVP & Regulatory & Quality Jama Pitman , Chief Commercial Officer Daniel C. Martin , and Chief Financial Officer Thomas Patrick Kelly .
Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary
Over the past 18 months, Steven L. Hoerter made 2 insider transaction in Deciphera Pharmaceuticals Inc (DCPH) with a net sale of 52,237. Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 23,797 shares made by Daniel C. Martin , a net sale of 12,184 shares made by Matthew L Sherman , and a net sale of 9,198 shares made by Thomas Patrick Kelly .
In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 105,002 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 95,002 shares.
Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Deciphera Pharmaceuticals Inc Insider Transactions
Steven L. Hoerter Mailing Address
Above is the net worth, insider trading, and ownership report for Steven L. Hoerter. You might contact Steven L. Hoerter via mailing address: C/o Deciphera Pharmaceuticals, Inc., 200 Smith Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
